Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)

ClinicalTrials.gov ID: NCT03191864

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03191864. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus, characterized by eosinophilic infiltration and gastrointestinal symptoms. Swallowed, topically acting corticosteroids, such as fluticasone, appear to be effective in resolving acute clinical and pathological features of EoE. APT-1011 is an orally disintegrating tablet (ODT) formulation of fluticasone propionate. This study is designed to compare the efficacy and safety of APT-1011 with placebo in adults with EoE for an initial 12-week treatment period, followed by an additional 40-week maintenance treatment phase. Histologic response, pharmacokinetics, and dysphagia will be assessed.

Study identification

NCT ID
NCT03191864
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Adare Pharmaceuticals, Inc.
Industry
Enrollment
106 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 22, 2017 (Actual)
Primary completion
Jan 3, 2019 (Actual)
Completion
Oct 23, 2019 (Actual)
Last update posted
Apr 26, 2023

2017 – 2019

United States locations

U.S. sites
51
U.S. states
23
U.S. cities
48
Facility City State ZIP Site status
Del Sol Research Management, LLC Chandler Arizona 85224 —
Del Sol Research Management, LLC Tucson Arizona 85710 —
Arkansas Gastroenterology, P.A. Sherwood Arkansas 72120 —
Hope Clinical Research Canoga Park California 91303 —
TriWest Research Associates, LLC El Cajon California 92020-4124 —
SC Clinical Research, Inc. Garden Grove California 92844 —
Beverly Hills Center for Digestive Health Los Angeles California 90048 —
Focilmed Oxnard California 93030 —
Precision Research Institute, LLC San Diego California 92114 —
Medical Associates Research Group, Inc. San Diego California 92123 —
Care Access Research LLC San Pablo California 94806 —
Stanford University School of Medicine Stanford California 94305-2200 —
St. Jude Healthcare Yorba Linda California 92886 —
Western Connecticut Health Network Danbury Connecticut 06810 —
Medical Research Center of Connecticut, LLC Hamden Connecticut 06518 —
Eastern Research, Inc. Hialeah Florida 33013 —
Nature Coast Clinical Research, LLC Inverness Florida 34452 —
Sunrise Medical Research Lauderdale Lakes Florida 33319 —
DBC Research, Corp Pembroke Pines Florida 33029 —
Northwestern Medical Faculty Foundation Chicago Illinois 60611 —
Southwest Gastroenterology Oak Lawn Illinois 60453-3767 —
Rockford Gastroenterology Associates, Ltd. Rockford Illinois 61107 —
MediSphere Medical Research Center, an AMR affiliate Evansville Indiana 47714 —
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 66606 —
Gastroenterology Associates Hazard Kentucky 41701 —
Clinical Trials of America, Inc. West Monroe Louisiana 71291 —
Henry Ford Medical Center Novi Michigan 48377-3600 —
Metro Health Wyoming Michigan 49519 —
St. Louis Center for Clinical Research St Louis Missouri 63128 —
Long Island Gastrointestinal Research Group, LLP Great Neck New York 11023 —
Weill Cornell Medical College New York New York 10021 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 —
Research Institute of the Carolinas, PLC Mooresville North Carolina 28117 —
Carolina's GI Research, LLC Raleigh North Carolina 27607 —
Wake Research Associates, LLC Raleigh North Carolina 27612 —
PMG Research of Salisbury, LLC Salisbury North Carolina 28144 —
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45231 —
Aventiv Research Inc. Columbus Ohio 43231 —
Unity Clinical Research Oklahoma City Oklahoma 73118 —
Allergy and Asthma Center of South Oregon Medford Oregon 97504 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Digestive Disease Associates, Ltd. Wyomissing Pennsylvania 19610 —
Rapid City Medical Center, LLP Rapid City South Dakota 57701 —
Advanced Gastroenterology Union City Tennessee 38261 —
Avant Research Associates, LLC - Austin Austin Texas 78704 —
Avant Research Associates, LLC Beaumont Texas 77702 —
DHAT Research Institute Richardson Texas 75082 —
Advanced Research Institute Ogden Utah 84405 —
University of Utah Salt Lake City Utah 84108 —
Care Access Research LLC Salt Lake City Utah 84124 —
Verity Research Inc Fairfax Virginia 22031 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03191864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2023 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.